US Patent Issued to Eli Lilly and Co. on June 23 for "Cocrystalline forms of FGFR3 inhibitors" (Indiana Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,483, issued on June 23, was assigned to Eli Lilly and Co. (Indianapolis).

"Cocrystalline forms of FGFR3 inhibitors" was invented by David Andrew Coates (New Palestine, Ind.), Lori Raquel Hilden (Indianapolis), Gislaine Kuminek (Indianapolis) and Jeffrey A. Peterson (Carmel, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are cocrystalline forms of FGFR3 inhibitors and gallic acid or nicotinamide coformers useful in the treatment and prevention of diseases which can be treated with a FGFR3 inhibitor, including FGFR3-associated diseases and disorders, characterizations and methods of making these cocrystalline forms."

The patent w...